Fingerprint
Dive into the research topics of 'Southwest Oncology Group study S0413: A phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically